"CHO Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CELL LINE derived from the ovary of the Chinese hamster, Cricetulus griseus (CRICETULUS). The species is a favorite for cytogenetic studies because of its small chromosome number. The cell line has provided model systems for the study of genetic alterations in cultured mammalian cells.
| Descriptor ID |
D016466
|
| MeSH Number(s) |
A11.251.210.200 A11.436.155
|
| Concept/Terms |
CHO Cells- CHO Cells
- CHO Cell
- Cell, CHO
- Cells, CHO
|
Below are MeSH descriptors whose meaning is more general than "CHO Cells".
Below are MeSH descriptors whose meaning is more specific than "CHO Cells".
This graph shows the total number of publications written about "CHO Cells" by people in this website by year, and whether "CHO Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 2 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 4 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 22 | 23 |
| 2018 | 1 | 30 | 31 |
| 2019 | 0 | 8 | 8 |
| 2020 | 0 | 7 | 7 |
| 2021 | 0 | 12 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "CHO Cells" by people in Profiles.
-
ß-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells. J Infect Dis. 2021 08 02; 224(3):415-419.
-
Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by a-1 Antitrypsin. Int J Mol Sci. 2021 Jul 26; 22(15).
-
Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak. Biotechnol Prog. 2021 09; 37(5):e3186.
-
Pharmacokinetic profiles of a SARS-COV-2 neutralizing antibody BD-604 in cynomolgus monkeys. Drug Test Anal. 2021 Oct; 13(10):1727-1734.
-
Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters. J Pharmacol Exp Ther. 2021 10; 379(1):96-107.
-
Evaluating a new mixed-mode resin Diamond MMC Mustang using Capto MMC ImpRes as a benchmark. Protein Expr Purif. 2021 10; 186:105930.
-
Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies. J Immunol Methods. 2021 08; 495:113082.
-
A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests. EBioMedicine. 2021 May; 67:103348.
-
Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia. Cell. 2021 06 10; 184(12):3192-3204.e16.
-
Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells. Anal Chem. 2021 05 04; 93(17):6839-6847.